Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver

Oncology Reports

Volumn 14, Issue 6, 2005, Pages 1543-1546

  Ueda, Hiroki ^a   Hamagami, Hiroko ^a   Tanaka, Hiroto ^a   Kida, Yohei ^a   Ichinose, Masakazu ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Combination hepatic arterial infusion; Liver metastasis; Ocular melanoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; NIMUSTINE; VINCRISTINE;

AGED; ARTICLE; CASE REPORT; DRUG EFFECT; EYE TUMOR; FATALITY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER; LIVER TUMOR; MALE; METASTASIS; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DACARBAZINE; EYE NEOPLASMS; FATAL OUTCOME; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER; LIVER NEOPLASMS; MALE; NIMUSTINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 33644696060     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.6.1543     Document Type: Article

References (20)

1. McCartney A: Pathologv of ocular melanoma. Br Med Bull 51: 678-693, 1995.
2. Becker JC, Terheyden P, Kampgen E, et al: Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 87: 840-845, 2002. (Pubitemid 35252958)
3. Leyvraz S, Spataro V, Bauer J, et al: Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 15: 2589-2595, 1997. (Pubitemid 27289889)
4. Banfalvi T, Gilde K, Boldizsar M, et al: Clinical significance of 5-S-cysteinyldopa monitoring in patients with malignant melanoma. Neoplasma 49: 121-125, 2002. (Pubitemid 34493674)
5. Pyrhonen S: The treatment of metastatic uveal melanoma. Eur J Cancer 34: S27-30, 1998.
6. Seregard S and Kock E: Prognostic indicators following enucleation for posterior uveal melanoma. Acta Ophthalmol Scand 73: 340-344, 1995.
7. Shields C: Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc 98: 471-492, 2000.
8. Shields CL, Naseripour M, Cater J, et al: Plaque radiotherapy for large posterior uveal melanomas in 354 consecutive patients. Ophthalmology 109: 1838-1849, 2002.
9. Tuomaala S, Eskelin S, Tarkkanen A, et al: Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci 43: 3399-3408, 2002. (Pubitemid 35334346)
10. Mavligit GM, Charnsangavej C, Carrasco CH, et al: Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 260: 974-976, 1988.
11. Choti MA and Bulkley GB: Management of hepatic metastases. Liver Transpl Surg 5: 65-80, 1999. (Pubitemid 29037357)
12. Feun LG, Reddy KR, Scagnelli T, et al: A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancer. Am J Clin Oncol 22: 375-380, 1999. (Pubitemid 30257636)
13. Cantore M, Fiorentini G, Aitini E, et al: Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumori 80: 37-39, 1994. (Pubitemid 24161620)
14. Kivela T, Suciu S, Hansson J, et al: Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer 39: 1115-1120, 2003. (Pubitemid 36555869)
15. Pyrhonen S, Hahka-Kemppinen M, Muhonen T, et al: Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma. Cancer 95: 2366-2372, 2002. (Pubitemid 35351144)
16. Umeda T, Aoki K, Yokoyama A, et al: Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma. J Dermatol 25: 569-572, 1998. (Pubitemid 28484049)
17. Nagatani T, Ichiyama S, Miyakawa K, et al: DAV malignant melanoma treated with natural interferons alfa and beta and DAV. Eur J Cancer 28A: 1774, 1992.
18. Soni S, Lee DS, DiVito JJ, et al: Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide. J Pediatr Hematol Oncol 24: 488-491, 2002.
19. Bedikian AY, Legha SS, Mavligit G, et al: Treatment of uveal melanoma metastatic to the liver. Cancer 76: 1665-1670, 1995.
20. Gragoudas ES, Egan KM, Seddon JM, et al: Survival of patients with metastases from uveal melanoma. Ophthalmology 98: 383-390, 1991.